1 May 2026Injectable drugs
Metronidazole injectable
Metronidazole injectable guidance for severe anaerobic bacterial infections.
Prescription under medical supervision
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.
Therapeutic action
Antiprotozoal, antibacterial.
Indications
Severe infections due to anaerobic bacteria such as Bacteroides species and Clostridium species.
Forms and strengths, route of administration
- 500 mg in 100 ml vial or bag (5 mg/ml), for infusion to be administered over 30 minutes.
Dose
- Child 1 month and over: 10 mg/kg every 8 hours, maximum 1500 mg daily.
- Adult: 500 mg every 8 hours.
Duration
According to indication. Change to oral treatment as soon as possible.
Contra-indications, adverse effects, precautions
- Do not administer to patients with allergy to metronidazole or another nitroimidazole such as tinidazole or secnidazole.
- Do not drink alcohol during treatment.
- May cause gastrointestinal disturbances, brownish urine, allergic reactions, headache, and dizziness.
- Monitor combination with anticoagulants, lithium, phenytoin, and ergometrine.
- Administer with caution and reduce the total daily dose to one third, given once daily, in patients with severe hepatic impairment.
- Pregnancy: no contra-indication.
- Breast-feeding: avoid.
- Metronidazole is as effective by oral route as by parenteral route.
- Do not add any drug in the infusion vial.
Source
MSF Essential drugs practical guidelines (January 2026)
This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.
Rate this guide
Be the first to rate this guide.
